Gastrointestinal manifestations of endocrine disease

World Journal of Gastroenterology

Volumn 12, Issue 20, 2006, Pages 3174-3179

  Maser, Christina ^a   Toset, Arnbjorn ^a   Roman, Sanziana ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Autoimmune thyroid disease; Functional thyroid disease; Islet cell tumors; Thyroid malignancy

Indexed keywords

ANTINEOPLASTIC AGENT; ANTITHYROID AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C PEPTIDE; CALCITONIN; CATECHOLAMINE; CORTICOTROPIN; DOXORUBICIN; FLUOROURACIL; GHRELIN; GLUTEN; GLYCOSAMINOGLYCAN; HLA DR3 ANTIGEN; INSULIN; LEVOTHYROXINE; NEUROTENSIN; OCTREOTIDE; PANCREAS POLYPEPTIDE; PROPRANOLOL; SOMATOSTATIN; STREPTOZOCIN; THYROID HORMONE; THYROXINE; VASOACTIVE INTESTINAL POLYPEPTIDE;

AUTOIMMUNE DISEASE; CLINICAL FEATURE; CRYOTHERAPY; ENDOCRINE DISEASE; ENDOCRINE TUMOR; GASTRINOMA; GASTROINTESTINAL DISEASE; GASTROSCOPY; GLUCAGONOMA; HASHIMOTO DISEASE; HUMAN; HYPERTHYROIDISM; INSULINOMA; MULTIPLE ENDOCRINE NEOPLASIA; NEUROENDOCRINE TUMOR; PANCREAS ISLET CELL TUMOR; PANCREAS RESECTION; PANCREAS TRANSPLANTATION; PANCREATICODUODENECTOMY; REVIEW; SOMATOSTATINOMA; SYMPTOMATOLOGY; THYROID CANCER; THYROID DISEASE; THYROTOXICOSIS; VIPOMA;

EID: 33745076176     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i20.3174     Document Type: Review

References (58)

1. Wegener M, Wedmann B, Langhoff T, Schaffstein J, Adamek R. Effect of hyperthyroidism on the transit of a caloric solid-liquid meal through the stomach, the small intestine, and the colon in man. J Clin Endocrinol Metab 1992; 75: 745-749
2. Tinker MB. Discussion of paper by Verbrycke JR. Masked gastrointestinal hyperthyroidism. JAMA 1931; 97: 515-516
3. Karaus M, Wienbeck M, Grussendorf M, Erckenbrecht JF, Strohmeyer G. Intestinal motor activity in experimental hyperthyroidism in conscious dogs. Gastroenterology 1989; 97: 911-919
4. Hoogendoorn EH, Cools BM. Hyperthyroidism as a cause of persistent vomiting. Neth J Med 2004; 62: 293-296
5. Chiu WY, Yang CC, Huang IC, Huang TS. Dysphagia as a manifestation of thyrotoxicosis: report of three cases and literature review. Dysphagia 2004; 19: 120-124
6. Branski D, Levy J, Globus M, Aviad I, Keren A, Chowers I. Dysphagia as a primary manifestation of hyperthyroidism. J Clin Gastroenterol 1984; 6: 437-440
7. Bassotti G, Pagliacci MC, Nicoletti I, Pelli MA, Morelli A. Intestinal pseudoobstruction secondary to hypothyroidism. Importance of small bowel manometry. J Clin Gastroenterol 1992; 14: 56-58
8. Lu CL, Montgomery P, Zou X, Orr WC, Chen JD. Gastric myoelectrical activity in patients with cervical spinal cord injury. Am J Gastroenterol 1998; 93: 2391-2396
9. Pfaffenbach B, Adamek RJ, Hagelmann D, Schaffstein J, Wegener M. Effect of hyperthyroidism on antral myoelectrical activity, gastric emptying and dyspepsia in man. Hepatogastroenterology 1997; 44: 1500-1508
10. Tenore A, Fasano A, Gasparini N, Sandomenico ML, Ferrara A, Di Carlo A, Guandalini S. Thyroxine effect on intestinal Cl-/ HC03- exchange in hypo- and hyperthyroid rats. J Endocrinol 1996; 151: 431-437
11. Thomas FB, Caldwell JH, Greenberger NJ. Steatorrhea in thyrotoxicosis. Relation to hypermotility and excessive dietary fat. Ann Intern Med 1973; 78: 669-675
12. Greenspan FS, Rapaport B. Thyroid gland. In Basic and Clinical Endocrinology FS Greenspan, JD Baxter (eds). Norwalk, Connecticut, Appleton and Lange, 1992: 188-246
13. Crail HW. Multiple primary malignancy arising in the rectum, brain, and thyroid. Report of a case. US Med Bull 1949; 49: 123-128
14. Camiel MR, Mule JE, Alexander LL, Benninghoff DL. Association of thyroid carcinoma with Gardner's syndrome in siblings. N Engl J Med 1968; 278: 1056-1058
15. Plail RO, Bussey HJ, Glazer G, Thomson JP. Adenomatous polyposis: an association with carcinoma of the thyroid. Br J Surg 1987; 74: 377-380
16. Perrier ND, van Heerden JA, Goellner JR, Williams ED, Gharib H, Marchesa P, Church JM, Fazio VW, Larson DR. Thyroid cancer in patients with familial adenomatous polyposis. World J Surg 1998; 22: 738-742; discussion 743
17. Cetta F, Toti P, Petracci M, Montalto G, Disanto A, Lore F, Fusco A. Thyroid carcinoma associated with familial adenomatous polyposis. Histopathology 1997; 31: 231-236
18. Harach HR, Williams GT, Williams ED. Familial adenomatous polyposis associated thyroid carcinoma: a distinct type of follicular cell neoplasm. Histopathology 1994; 25: 549-561
19. Hizawa K, Iida M, Yao T, Aoyagi K, Oohata Y, Mibu R, Yamasaki K, Hirata T, Fujishima M. Association between thyroid cancer of cribriform variant and familial adenomatous polyposis. J Clin Pathol 1996; 49: 611-613
20. Iwama T, Mishima Y, Utsunomiya J. The impact of familial adenomatous polyposis on the tumorigenesis and mortality at the several organs. Its rational treatment. Ann Surg 1993; 217: 101-108
21. Bulow C, Bulow S. Is screening for thyroid carcinoma indicated in familial adenomatous polyposis? The Leeds Castle Polyposis Group. Int J Colorectal Dis 1997; 12: 240-242
22. Cetta F, Pelizzo MR, Curia MC, Barbarisi A. Genetics and clinicopathological findings in thyroid carcinomas associated with familial adenomatous polyposis. Am J Pathol 1999; 155: 7-9
23. Cameselle-Teijeiro J, Chan JK. Cribriform-morular variant of papillary carcinoma: a distinctive variant representing the sporadic counterpart of familial adenomatous polyposis-associated thyroid carcinoma? Mod Pathol 1999; 12: 400-411
24. Cetta F, Olschwang S, Petracci M, Montalto G, Baldi C, Zuckermann M, Mariani Costantini R, Fusco A. Genetic alterations in thyroid carcinoma associated with familial adenomatous polyposis: clinical implications and suggestions for early detection. World J Surg 1998; 22: 1231-1236
25. Ng SB, Sittampalam K, Goh YH, Eu KW. Cribriform-morular variant of papillary carcinoma: the sporadic counterpart of familial adenomatous polyposis-associated thyroid carcinoma. A case report with clinical and molecular genetic correlation. Pathology 2003; 35: 42-46
26. Cetta F, Montalto G, Gori M, Curia MC, Cama A, Olschwang S. Germline mutations of the APC gene in patients with familial adenomatous polyposis-associated thyroid carcinoma: results from a European cooperative study. J Clin Endocrinol Metab 2000; 85: 286-292
27. Tomoda C, Miyauchi A, Uruno T, Takamura Y, Ito Y, Miya A, Kobayashi K, Matsuzuka F, Kuma S, Kuma K, Kakudo K. Cribriform-morular variant of papillary thyroid carcinoma: clue to early detection of familial adenomatous polyposis-associated colon cancer. World J Surg 2004; 28: 886-889
28. Sollid LM, Thorsby E. The primary association of celiac disease to a given HLA-DQ alpha/beta heterodimer explains the divergent HLA-DR associations observed in various Caucasian populations. Tissue Antigens 1990; 36: 136-137
29. Dalton TA, Bennett JC. Autoimmune disease and the major histocompatibility complex: therapeutic implications. Am J Med 1992; 92: 183-188
30. Hakanen M, Luotola K, Salmi J, Laippala P, Kaukinen K, Collin P. Clinical and subclinical autoimmune thyroid disease in adult celiac disease. Dig Dis Sci 2001; 46: 2631-2635
31. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996; 20: 1161-1181
32. Certanni M. Atrophic body gastritis in patients with autoimmune thyroid disease. Arch Intern Med 1999; 159: 1726-1730
33. Segni M, Borrelli O, Pucarelli I, Delle Fave G, Pasquino AM, Annibale B. Early manifestations of gastric autoimmunity in patients with juvenile autoimmune thyroid diseases. J Clin Endocrinol Metab 2004; 89: 4944-4948
34. Hsing AW, Hansson LE, McLaughlin JK, Nyren O, Blot WJ, Ekbom A, Fraumeni JF Jr. Pernicious anemia and subsequent cancer. A population-based cohort study. Cancer 1993; 71: 745-750
35. Kokkola A, Sjoblom SM, Haapiainen R, Sipponen P, Puolakkainen P, Jarvinen H. The risk of gastric carcinoma and carcinoid tumours in patients with pernicious anaemia. A prospective follow-up study. Scand J Gastroenterol 1998; 33: 88-92
36. De Block CE, De Leeuw IH, Bogers JJ, Pelckmans PA, Ieven MM, Van Marck EA, Van Acker KL, Van Gaal LF. Autoimmune gastropathy in type 1 diabetic patients with parietal cell antibodies: histological and clinical findings. Diabetes Care 2003; 26: 82-88
37. Friesen SR. The Endocrine Gut and Pancreas. In Welbourn, R, editor, The History of Endocrine Surgery, New York: Praeger, 1990: 237-255
38. Doppman JL, Chang R, Fraker DL, Norton JA, Alexander HR, Miller DL, Collier E, Skarulis MC, Gorden P. Localization of insulinomas to regions of the pancreas by intra-arterial stimulation with calcium. Ann Intern Med 1995; 123: 269-273
39. Turner JO, Wren AM, Jackson JE, Thakker RV, Meeran K. Localization of Gastrinomas by Selective Intra-arterial Calcium Injection. Clin Endocrinol 2002; 57: 821-825
40. Proye CA, Lokey JS. Current concepts in functioning endocrine tumors of the pancreas. World J Surg 2004; 28: 1231-1238
41. Hamoud AK, Khan MF, Aboalmaali N, Usadel KH, Wullstein C, Vogl TJ. Mangan-enhanced MR imaging for the detection and localisation of small pancreatic insulinoma. Eur Radiol 2004; 14: 923-925
42. Wada M, Komoto I, Doi R, Imamura M. Intravenous calcium injection test is a novel complementary procedure in differential diagnosis for gastrinoma. World J Surg 2002; 26: 1291-1296
43. Brandle M, Pfammatter T, Spinas GA, Lehmann R, Schmid C. Assessment of selective arterial calcium stimulation and hepatic venous sampling to localize insulin-secreting tumours. Clin Endocrinol (Oxf) 2001; 55: 357-362
44. Eriksson B, Bergstrom M, Sundin A, Juhlin C, Orlefors H, Oberg K, Langstrom B. The role of PET in localization of neuroendocrine and adrenocortical tumors. Ann N Y Acad Sci 2002; 970: 159-169
45. Assalia A, Gagner M. Laparoscopic pancreatic surgery for islet cell tumors of the pancreas. World J Surg 2004; 28: 1239-1247
46. Thompson GB, Young WF. Multiple Endocrine Neoplasia Type 1. In Clark OH, Duh Q-Y, Kebebew E, editors. Textbook of Endocrine Surgery, 2nd edition. Philedelphia: Saunders, 2005: 673-690
47. Bouhhman MP, Karam JM, Shaver J, Siperstein AE, DeLorimier AA, Clark OH. Localization of Insulinomas. Arch Surg 1999; 134: 818-823
48. Norton JA, Fraker DL, Alexander HR, Venzon DJ, Doppman JL, Serrano J, Goebel SU, Peghini PL, Roy PK, Gibril F, Jensen RT. Surgery to cure the Zollinger-Ellison syndrome. N Engl J Med 1999; 341: 635-644
49. Imamura M, Minematsu S, Tobe T, Adachi H, Takahashi K. Selective arterial secretin injection test for localization of gastrinoma. Nippon Geka Gakkai Zasshi 1986; 87: 671-679
50. Imamura M, Takahashi K, Adachi H, Minematsu S, Shimada Y, Naito M, Suzuki T, Tobe T, Azuma T. Usefulness of selective arterial secretin injection test for localization of gastrinoma in the Zollinger-Ellison syndrome. Ann Surg 1987; 205: 230-239
51. Smith SL, Branton SA, Avino AJ, Martin JK, Klingler PJ, Thompson GB, Grant CS, van Heerden JA. Vasoactive intestinal polypeptide secreting islet cell tumors: a 15-year experience and review of the literature. Surgery 1998; 124: 1050-1055
52. Koch TR, Michener SR, Go VL. Plasma vasoactive intestinal polypeptide concentration determination in patients with diarrhea. Gastroenterology 1991; 100: 99-106s with Diarrhea. Gastroenterology 1991; 100: 99-106
53. Rindi G, Torsello A, Locatelli V, Solcia E. Ghrelin expression and actions: a novel peptide for an old cell type of the diffuse endocrine system. Exp Biol Med (Maywood) 2004; 229: 1007-1016
54. Liang H, Wang P, Wang XN, Wang JC, Hao XS. Management of nonfunctioning islet cell tumors. World J Gastroenterol 2004; 10: 1806-1809
55. Guo KJ, Liao HH, Tian YL, Guo RX, He SG, Shen K. Surgical treatment of nonfunctioning islet cell tumor: report of 41 cases. Hepatobiliary Pancreat Dis Int 2004; 3: 469-472
56. Skogseid B, Rastad J, Akerstrom G. Pancreatic Endocrine Tumors in Multiple Endocrine Neoplasia Type 1. In Doherty GM and Skogseid B editors Surgical Endocrinology. Philedelphia, Lippincott Williams & Wilkins 2001
57. Imamura M. Treatment for pancreatic endocrine tumors with or without multiple endocrine neoplasia type 1. Nippon Geka Gakkai Zasshi 2005; 106: 472-478
58. Cohen MS, Phay JE, Albinson C, DeBenedetti MK, Skinner MA, Lairmore TC, Doherty GM, Balfe DM, Wells SA Jr, Moley JF. Gastrointestinal manifestations of multiple endocrine neoplasia type 2. Ann Surg 2002; 235: 648-654; discussion 654-655